Neuronal amyloid β 1-42 (Aβ 1-42 ) accumulation is considered an upstream event in Alzheimer's disease pathogenesis. Here we report the mechanism on synaptic activity-independent Aβ 1-42 uptake in vivo. When Aβ 1-42 uptake was compared in hippocampal slices after incubating with Aβ 1-42 , In vitro Aβ 1-42 uptake was preferentially high in the dentate granule cell layer in the hippocampus. Because the rapid uptake of Aβ 1-42 with extracellular Zn 2+ is essential for Aβ 1-42 -induced cognitive decline in vivo, the uptake mechanism was tested in dentate granule cells in association with synaptic activity. In vivo rapid uptake of Aβ 1-42 was not modified in the dentate granule cell layer after co-injection of Aβ 1-42 and tetrodotoxin, a Na + channel blocker, into the dentate gyrus. Both the rapid uptake of Aβ 1-42 and Zn 2+ into the dentate granule cell layer was not modified after co-injection of CNQX, an AMPA receptor antagonist, which blocks extracellular Zn 2+ influx, Both the rapid uptake of Aβ 1-42 and Zn
In vivo synaptic activity-independent co-uptakes of amyloid β 1- 42 and Zn Here we report the mechanism on synaptic activity-independent Aβ 1-42 uptake in vivo. When Aβ 1-42 uptake was compared in hippocampal slices after incubating with Aβ 1-42 , In vitro Aβ 1-42 uptake was preferentially high in the dentate granule cell layer in the hippocampus. Because the rapid uptake of Aβ 1-42 with extracellular Zn 2+ is essential for Aβ 1-42 -induced cognitive decline in vivo, the uptake mechanism was tested in dentate granule cells in association with synaptic activity. In vivo rapid uptake of Aβ 1-42 was not modified in the dentate granule cell layer after co-injection of Aβ and tetrodotoxin, a Na + channel blocker, into the dentate gyrus. Both the rapid uptake of Aβ 1-42 and Zn 2+ into the dentate granule cell layer was not modified after co-injection of CNQX, an AMPA receptor antagonist, which blocks extracellular Zn 2+ influx, Both the rapid uptake of Aβ 1-42 and Zn
2+
into the dentate granule cell layer was not also modified after either co-injection of chlorpromazine or genistein, an endocytic repressor. the present study suggests that Aβ 1-42 and Zn 2+ are synaptic activity-independently co-taken up into dentate granule cells in the normal brain and the co-uptake is preferential in dentate granule cells in the hippocampus. We propose a hypothesis that Zn-Aβ 1-42 oligomers formed in the extracellular compartment are directly incorporated into neuronal plasma membranes and form Zn 2+ -permeable ion channels.
Alzheimer's disease (AD) has a preclinical phase of 20-30 years prior to clinical onset and is the most common cause of dementia 1, 2 . Amyloid-β (Aβ) peptides are produced by processing of amyloid precursor protein (APP) 3, 4 and have a characteristic of self-assembly into oligomers in the extracellular compartment 5 . Aβ and Aβ 1-42 are the two major isoforms 6 . Aβ 1-42 more readily forms oligomers than Aβ and is more neurotoxic 7 . Formation and propagation of misfolded aggregates of Aβ 1-42 may contribute to AD pathogenesis rather than those of Aβ . C-Terminal carboxylate anion of Aβ , which forms the C-terminal hydrophobic core, leads to accelerate neurotoxic oligomerization 8 . C-Terminal Ala42 that is absent in Aβ 1-40 forms a salt bridge with Lys28 and constructs a self-recognition molecular switch. The switch is the Aβ 1-42 -mediated self-replicating amyloid-propagation machinery 9 . In AD pathogenesis, Zn 2+ has been implicated by inducing rapid Aβ oligomerization [10] [11] [12] . The aggregation property of Aβ 1-42 is accelerated with Zn 2+ , followed by much higher affinity of Aβ 
, which leads to neuronal Zn-Aβ 1-42 uptake and then synaptic dysfunction. In the hippocampus, Aβ 1-42 released into the extracellular compartment can capture Zn 2+ , which is estimated to be approximately 10 nM in the extracellular fluid 13 , even at 500 pM Aβ in vivo. We have reported that Aβ 1-42 takes Zn 2+ as a cargo into dentate granule cells in the normal brain, followed by cognitive decline [14] [15] [16] . Although the mechanism of Zn-Aβ 21 .
In the present study, we postulate that Zn-Aβ 1-42 oligomers formed in the extracellular compartment form Zn 2+ -permeable plasma membrane pores, based on the evidence of permeation of Zn 2+ through Ca 2+ channels 22, 23 . Here we report the mechanism on synaptic activity-independent Aβ 1-42 uptake in vivo.
Results
When Aβ 1-42 is bound to extracellular Zn 2+ in vivo, Aβ 1-42 is rapidly taken up into dentate granule cells and affects memory via attenuated LTP [14] [15] [16] . Both uptake of Aβ and Zn 2+ are observed 5 min after Aβ 1-42 injection into the dentate gyrus, followed by Aβ toxicity and are blocked by coinjection of CaEDTA, an extracellular Zn 2+ chelator, followed by blockade of Aβ toxicity. Thus, we need to clarify the mechanism of the rapid uptake of Aβ in vivo, which is linked with Aβ toxicity. On the other hand, endogenous Zn 2+ released from the hippocampal slices promotes Aβ 1-42 uptake (retention), which is determined by in vitro Aβ immunohistochemistry (monoclonal antibody 4G8), in the absence of additional extracellular Zn 2+ 15 . In the present study, Aβ 1-42 uptake was determined in rat hippocampal slices 15 min after incubation with Aβ 1-42 , Aβ 1-42 uptake was preferentially high in the dentate granule cell layer in the hippocampus, compared with the CA3 and CA1 pyramidal cell layer (Fig. 1) .
To examine the involvement of neuronal activity in Aβ 1-42 uptake, Aβ 1-42 and tetrodotoxin, a Na + channel blocker, was co-injected into the dentate gyrus of rats. The present dose (15 μM) of tetrodotoxin was determined based on the in vivo action as a Na + channel blocker (10 μM) 24 . Aβ 1-42 uptake was determined by ex vivo Aβ immunohistochemistry 5 min after the co-injection. The rapid uptake of Aβ was not modified in the dentate granule cell layer even by co-injection of tetrodotoxin (Fig. 2) .
AMPA receptor activation induces extracellular Zn 2+ influx in vivo, which is blocked in the presence of 2 mM CNQX, and the excess influx leads to cognitive decline via attenuated LTP 25, 26 . The present dose of CNQX (2 mM) was used according to the previous papers. Both the rapid uptake of Aβ and Zn 2+ into the dentate granule cell layer was not modified by co-injection of CNQX (Fig. 3) , suggesting Aβ 1-42 -mediated extracellular Zn 2+ influx. We examined whether endocytosis is involved in the rapid uptake of Aβ 1-42 and Zn 2+ . Chlorpromazine (500 μM), a clathrin/caveolae-mediated endocytosis blocker, was used based on the in vivo action as a blocker www.nature.com/scientificreports www.nature.com/scientificreports/ (200 μM) 27 . Genistein (250 μM), a caveolae/raft-mediated endocytosis blocker, was used based on the blocking effect on the primary entry pathway for aquareovirus (<200 μM) 28 . Both the rapid uptake of Aβ and Zn 2+ into the dentate granule cell layer was not also modified by either co-injection of chlorpromazine ( 
Discussion
In vivo LTP at medial perforant pathway-dentate granule cell synapses, which is closely linked to object recognition memory 29 , is not affected even under perfusion with 1,000 nM Aβ and subsequently attenuates LTP 15 . The evidence is consistent with Aβ 1-42 -induced object recognition memory deficit, which is also rescued by CaEDTA and ZnAF-2DA, an intracellular Zn 2+ chelator 13 . Thus, extracellular Zn 2+ is essential for Aβ 1-42 -induced cognitive decline via attenuated LTP in the normal brain, consistent with in vivo complete blocking rapid uptake of Aβ and Zn 2+ into dentate granule cells after co-injection of Aβ and CaEDTA into the dentate gyrus 15 . In the present study, we tested the uptake mechanism of Aβ 1-42 oligomers in vitro and in vivo.
When Aβ 1-42 uptake was determined in hippocampal slices after incubation with Aβ 1-42 , Aβ 1-42 uptake was preferentially high in the dentate granule cell layer in the hippocampus. Aβ 1-42 uptake was also considerably high in the CA3 pyramidal cell layer, while Aβ 1-42 uptake was not observed in the CA1 pyramidal cell layer. Extracellular Zn 2+ interaction with Aβ 1-42 is essential for Aβ 1-42 uptake into dentate granule cells in vivo and its essentiality is the same even under in vitro hippocampal slice condition 15 . Endogenous Zn 2+ release from the hippocampal slices is required for the Aβ 1-42 uptake. In hippocampal slices bathed in ACSF without Zn 2+ , extracellular Zn 2+ level determined with ZnAF-2 is the highest in the hilus close to the dentate granule cell layer and the second highest in the stratum lucidum close to the CA3 pyramidal cell layer 30 1, 33, 34 . The perforant pathway-dentate granule cell synapses are vulnerable to Aβ synapse toxicity 35 , which may be linked with extracellular Zn 2+ -mediated Aβ 1-42 uptake into dentate granule cells. This uptake may be associated with the high level of extracellular Zn 2+ in the hilus that may be due to Zn 2+ release form mossy fibers. The mechanism of Aβ 1-42 uptake was tested in the dentate granule cell layer in vivo. When Aβ 1-42 was co-injected with tetrodotoxin, a Na + channel blocker, into the dentate gyrus, the rapid uptake of Aβ was not modified in the dentate granule cell layer. AMPA receptor activation induces extracellular Zn 2+ influx and the Figure 2 . In vivo uptake of Aβ in the dentate gyrus in the presence of tetrodotoxin. Aβ 1-42 immunostaining was determined in the dentate gyrus 5 min after injection of 50 μM Aβ 1-42 (n = 6), and 50 μM Aβ 1-42 + 15 μM tetrodotoxin (n = 8) in ACSF into the dentate gyrus of anesthetized rats (left). GCL, dentate granule cell layer. Bar, 50 μm. Aβ 1-42 uptake in the dentate granule cell layer determined with Alexa 633 intensity, which is represented by the ratio to the control (n = 12) without 50 μM Aβ 1-42 in ACSF expressed as 100%. *p < 0.05, vs. control.
www.nature.com/scientificreports www.nature.com/scientificreports/ excess influx leads to cognitive decline via attenuated LTP 25, 26 . In contrast, both the rapid uptake of Aβ 1-42 and Zn 2+ into the dentate granule cell layer was not modified after co-injection of CNQX, an AMPA receptor antagonist, suggesting that Zn-Aβ 1-42 oligomers are ionotropic glutamate receptor activation-independently taken up into dentate granule cells. Both the rapid uptake of Aβ and Zn 2+ into the dentate granule cell layer was not also modified after either co-injection of chlorpromazine or genistein, an endocytic repressor. It is likely that Zn-Aβ 1-42 oligomers are rapidly taken up into dentate granule cells without interaction with plasma membrane receptor proteins.
In human SH-SY5Y neuroblastoma, monomeric Aβ 1-42 is selectively internalized via clathrin-and dynamin-independent endocytosis compared to monomeric Aβ 1-40 36 . Genistein, a major phytoestrogen in soybean, may reduce the Aβ 1-42 -induced cell toxicity by suppressing the formation of toxic, cell membrane penetrating Aβ 1-42 oligomers in human SH-SY5Y neuroblastoma 37 . Zn 2+ interaction with Aβ 1-42 has not been taken into account in these in vitro cell culture systems, suggesting that Zn-Aβ 1-42 oligomers formed in vivo are taken up into dentate granule cells via a novel mechanism and causes cytotoxicity. On the other hand, Aβ production occurs in acidic vesicular organelles and contributes both to Aβ secretion and to the direct accumulation of Aβ within neurons 37 . Intracellular Aβ produced by the direct accumulation can exist as a monomeric form that further aggregates into oligomers and it may mediate pathological events 38 , although it is unknown whether Zn 2+ is involved in the pathological effects.
The Aβ ion channel hypothesis has been reported in AD pathogenesis. These authors have reported that Aβ peptides disrupt Ca 2+ homeostasis in neurons and increase intracellular Ca 2+ level, resulting in synaptic Figure 3 . In vivo uptake of Aβ and Zn 2+ in the dentate gyrus in the presence of CNQX. Aβ 1-42 immunostaining (upper-left) and Zn 2+ imaging (upper-right) were determined in the dentate gyrus 5 min after injection of 50 μM Aβ , and 50 μM Aβ 1-42 + 2 mM CNQX in ACSF into the dentate gyrus of anesthetized rats. GCL, dentate granule cell layer. Bar, 50 μm. Aβ 1-42 uptake in the dentate granule cell layer determined with Alexa 633 intensity, which is represented by the ratio to the control (control, n = 6; Aβ, n = 5; Aβ/CNQX, n = 6) without 50 μM Aβ in ACSF expressed as 100% (lower-left). Zn 2+ uptake in the dentate granule cell layer determined with ZnAF-2 intensity, which is represented by the ratio to the control (control, n = 11; Aβ, n = 10; Aβ/CNQX, n = 6) without 50 μM Aβ in ACSF expressed as 100% (lower-right). *p < 0.05, **p < 0.01, vs. control. (2019) 9:6498 | https://doi.org/10.1038/s41598-019-43012-0 www.nature.com/scientificreports www.nature.com/scientificreports/ dysfunction and neurodegeneration. The hypothesis is based on the results from in vitro experimental systems such as artificial membranes and neuronal culture 18, 39 . Judging from capturing extracellular Zn 2+ with high picomolar (100-500 pM) Aβ in the hippocampal extracellular compartment, which disrupts Zn 2+ homeostasis in neurons and increases intracellular Zn 2+ level 14 , the Aβ-mediated Ca 2+ channel hypothesis might be changed into the Aβ 1-42 -mediated Zn 2+ channel hypothesis in AD pathogenesis. Because Aβ stain is observed around the nuclei in dentate granule cells 15 , a portion of Aβ 1-42 is co-taken up with Zn 2+ into dentate granule cells even if Aβ 1-42 -mediated Zn 2+ channels (pores) is formed in the plasma membrane. In conclusion, the present study suggests that amyloid β and Zn 2+ are synaptic activity-independently co-taken up into dentate granule cells in the normal brain and the co-uptake is preferential in dentate granule cells. We propose a hypothesis that Zn-Aβ oligomers formed in the extracellular compartment are directly incorporated into neuronal membranes and form Zn 2+ -permeable ion channels. Because extracellular Zn 2+ is age-relatedly increased in the rat hippocampus 40 , Zn-Aβ 1-42 oligomers are more readily produced in the extracellular compartment of the aged hippocampus, followed by vulnerability to Zn-Aβ 1-42 oligomers in aging 16, 41 . Therefore, controlling intracellular Zn 2+ dysregulation may be an effective strategy for overcoming AD pathogenesis.
experimental procedures
Animals and chemicals. Wistar rats (male, 7-9 weeks of age) were obtained from Japan SLC (Hamamatsu, Japan). Rats were housed under the standard laboratory conditions (23 ± 1 °C, 55 ± 5% humidity) and had access Figure 4 . In vivo uptake of Aβ and Zn 2+ in the dentate gyrus in the presence of chlorpromazine (CPZ). Aβ immunostaining (upper-left) and Zn 2+ imaging (upper-right) were determined in the dentate gyrus 5 min after injection of 50 μM Aβ , and 50 μM Aβ 1-42 + 500 μM chlorpromazine in ACSF into the dentate gyrus of anesthetized rats. GCL, dentate granule cell layer. Bar, 50 μm. Aβ 1-42 uptake in the dentate granule cell layer determined with Alexa 633 intensity, which is represented by the ratio to the control (control, n = 11; Aβ, n = 10; Aβ/CPZ, n = 5) without 50 μM Aβ in ACSF expressed as 100% (lower-left). Zn 2+ uptake in the dentate granule cell layer determined with ZnAF-2 intensity, which is represented by the ratio to the control (control, n = 10; Aβ, n = 9; Aβ/CNQX, n = 11) without 50 μM Aβ in ACSF expressed as 100% (lower-right). *p < 0.05, **p < 0.01, ***p < 0.001, vs. control.
www.nature.com/scientificreports www.nature.com/scientificreports/ to water and food ad libitum. Rats were used for experiments approximately 1 week after housing. All the experiments were performed according to the Guidelines for the Care and Use of Laboratory Animals in the University of Shizuoka, which refer to the American Association for Laboratory Animals Science and the guidelines laid down by the NIH (NIH Guide for the Care and Use of Laboratory Animals) in the USA. The present study has been approved by the Ethics Committee for Experimental Animals in the University of Shizuoka.
Synthetic human Aβ 1-42 was purchased from ChinaPeptides (Shanghai, China). Aβ was dissolved in saline at the time of need. Aβ 1-42 prepared in saline was mainly monomers with a small fraction of low order oligomers in SDS-PAGE 14 . ZnAF-
) is a membrane-permeable Zn 2+ indicator and was kindly supplied from Sekisui Medical Co., LTD (Hachimantai, Japan). This indicator is taken up into the cells through the plasma membrane and is hydrolyzed by esterase in the cytosol to produce ZnAF-2, which does not permeate the plasma membrane 42, 43 Hippocampal slice preparation. Rats were anesthetized with ether and decapitated under anesthesia. The brain was quickly removed from rats and bathed in ice-cold choline-ACSF, which consists of 124 mM choline chloride, 2.5 mM KCl, 2.5 mM MgCl 2 , 1.25 mM NaH 2 PO 4 , 0.5 mM CaCl 2 , 26 mM NaHCO 3 , and 10 mM glucose (pH 7.3) to block excessive neuronal excitation. Horizontal hippocampal slices (400 μm) were prepared in Figure 5 . In vivo uptake of Aβ and Zn 2+ in the dentate gyrus in the presence of genistein. Aβ 1-42 immunostaining (upper-left) and Zn 2+ imaging (upper-right) were determined in the dentate gyrus 5 min after injection of 50 μM Aβ , and 50 μM Aβ 1-42 + 250 μM genistein in ACSF into the dentate gyrus of anesthetized rats. GCL, dentate granule cell layer. Bar, 50 μm. Aβ 1-42 uptake in the dentate granule cell layer determined with Alexa 633 intensity, which is represented by the ratio to the control (control, n = 5; Aβ, n = 4; Aβ/genistein, n = 6) without 50 μM Aβ in ACSF expressed as 100% (lower-left). Zn 2+ uptake in the dentate granule cell layer determined with ZnAF-2 intensity, which is represented by the ratio to the control (control, n = 8; Aβ, n = 5; Aβ/ genistein, n = 5) without 50 μM Aβ in ACSF expressed as 100% (lower-right). *p < 0.05, vs. control.
www.nature.com/scientificreports www.nature.com/scientificreports/ ice-cold choline-ACSF by using a vibratome ZERO-1 (Dosaka Kyoto, Japan). Hippocampal slices were placed in ACSF at 25 °C for at least 30 minutes. All solutions were continuously bubbled with 95% O 2 and 5% CO 2 .
In vitro immunostaining. Hippocampal slices were bathed in 50 μM Aβ in ACSF for 15 min. Slices were then rinsed twice with ACSF for 5 min to remove extracellular agents, and fixed with paraformaldehyde (4% in 0.01 M PBS) for 15 min. Slices were rinsed in 0.01 M PBS three times. Slice tissues were blocked in 10% normal goat serum for 30 min, followed by rinse in 0.01 M PBS three times, incubated with 70% formic acid for 5 min, rinsed with 0.01 M PBS three times, and bathed at 4 °C in Aβ monoclonal antibody, 4G8 (COVANCE, 1:500 dilution in 0.01 M PBS) for 48 h. Slices were then rinsed with 0.01 M PBS three times, bathed in Alexa Fluor 633 goat anti-mouse IgG secondary antibody (1: 200 dilution in 0.01 M PBS) for 1 h, rinsed with 0.01 M PBS three times, bathed in 4′,6-diamidino-2-phenylindole (DAPI) for 10 min, rinsed again with 0.01 M PBS three times, and mounted on glass slides. Immunostaining images were obtained by using a confocal laser-scanning microscopic system (Nikon A1 confocal microscopes, Nikon Corp.) through a 10× objective. Florescence intensity was analyzed by the NIH Image J.
Ex vivo immunostaining.
Rats anesthetized with chloral hydrate (400 mg/kg) were placed in a stereotaxic apparatus. The skull was exposed and two burr holes were drilled. Injection cannulae (internal diameter, 0.15 mm; outer diameter, 0.35 mm) were bilaterally inserted into the dentate granule cell layer (4.0 mm posterior to the bregma, 2.3 mm lateral, 2.9 mm inferior to the dura) of the anesthetized rats. Thirty minutes later following recovery from the insertion damage, 50 μM Aβ 1-42 in ACSF, or 50 μM Aβ 1-42 with either 15 μM tetrodotoxin, a Na 2+ channel blocker, 2 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), an α-amino-3-hydroxy-5-methyl -4-isoxazolepropionate (AMPA) receptor antagonist, 500 μM chlorpromazine, a clathrin/caveolae-mediated endocytosis blocker, or 250 μM genistein, a caveolae/raft-mediated endocytosis blocker, in ACSF were bilaterally injected into the dentate granule cell layer at the rate of 0.25 μl/min for 8 min via the injection cannulae. Five minutes later, the brain was quickly removed from the rats and immunostaining images in hippocampal slices were obtained in the same manner except for changing the 10% goat serum with 5% goat serum. The positions of the injection cannulae were confirmed in the slice preparation.
In vivo intracellular Zn
2+ imaging. Fifty μM Aβ 1-42 in ACSF containing 100 μM ZnAF-2DA, or 50 μM Aβ 1-42 with either 15 μM tetrodotoxin, 2 mM CNQX, 500 μM chlorpromazine, or 250 μM genistein in ACSF containing 100 μM ZnAF-2DA was bilaterally injected via injection cannulae into the dentate granule cell layer of anesthetized rats at the rate of 0.25 μl/min for 8 min. Five minutes later, the hippocampal slices were prepared in the same manner. Slices were transferred to a chamber filled with ACSF, loaded with 2 μM Calcium Orange AM in ACSF for 30 min, and then rinsed in ACSF for 30 min. The hippocampal slices were transferred to a recording chamber filled with ACSF. The fluorescence of ZnAF-2 (laser, 488.4 nm; emission, 500-550 nm), and calcium orange (laser, 561.4 nm; emission, 570-620 nm) was measured with a confocal laser-scanning microscopic system (Nikon A1 confocal microscopes, Nikon Corp.). Calcium Orange AM was used to identify hippocampal regions in slices. The positions of the injection cannulae were confirmed in the slice preparation.
Data analysis. For multiple comparisons, differences between treated groups were analyzed by one-way ANOVA followed by post hoc testing using the Tukey's test. A value of p < 0.05 was considered significant (the statistical software, GraphPad Prism 5). Data were expressed as means ± standard error. The control group with vehicle was compared with the treated groups in all figures for the statistical analysis. In Fig. 1 , Aβ group in the DG was also compared with those in the CA3 and the CA1.
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